Wyeth Should Face Drug Rebate Claims In Court, States Say
Several states intervening in a whistleblower suit accusing Pfizer-owned Wyeth Pharmaceuticals of overcharging Medicaid by hundreds of millions of dollars for an acid reflux drug told a Massachusetts federal court Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article